Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. [electronic resource]
Producer: 20130411Description: 4882-91 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Area Under Curve
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Cell Proliferation
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Female
- Gene Rearrangement, T-Lymphocyte
- Graft vs Host Disease -- chemically induced
- Hematologic Neoplasms -- immunology
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Interleukin-7 -- genetics
- Interleukin-7 Receptor alpha Subunit -- immunology
- Male
- Metabolic Clearance Rate
- Middle Aged
- Receptors, Antigen, T-Cell -- genetics
- Recombinant Proteins -- adverse effects
- T-Lymphocytes -- drug effects
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.